RESYSTAANCT05391113
REward SYSTem in Autism Spectrum Disorder and Addictive Disorder
At risk: Primary completion moved at least 1 year 11 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 9 versions: 9 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion dates pushed to Jul 2028
- Eligibility criteria expanded, about 13 words
- Site contacts updated at 3 of 3 sites
- Collaborator revised
- Minor Site contacts updated at 3 of 3 sitesv8
Notable Trial status: Not Yet Recruiting to Recruitingv7 Show 4 more changesShow less
- Primary completion date: May 15, 2026 to Jul 27, 2026
- Study completion date: Oct 1, 2026 to Jan 27, 2027
- Start date changed from estimate of May 15, 2023 to Jul 27, 2023
- Site details revised at 3 of 3 sites
- Notable Start date: Apr 1, 2023 to May 15, 2023
- Primary completion date: Apr 1, 2026 to May 15, 2026
Notable Start date: Mar 1, 2023 to Apr 1, 2023v5 Show 4 more changesShow less
- Enrollment target: 54 to 78
- Primary completion date: Mar 1, 2026 to Apr 1, 2026
- Study completion date: Sep 1, 2026 to Oct 1, 2026
- Interventions: MRI (Diagnostic Test) to EEG (Diagnostic Test), MRI (Diagnostic Test)
Show 3 earlier versionsHide 3 earlier versions
- Notable Start date: Nov 9, 2022 to Mar 1, 2023
- Eligibility criteria shortened, about 6 words
- Primary completion date: Nov 9, 2025 to Mar 1, 2026
- Study completion date: Jan 9, 2026 to Sep 1, 2026
- Notable Start date: Sep 15, 2022 to Nov 9, 2022
- Primary completion date: Sep 15, 2025 to Nov 9, 2025
- Study completion date: Sep 16, 2025 to Jan 9, 2026
- Minor Study sites: 2 to 3v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (2)
Arms and interventions
Characterized by two main diagnostic criteria: a socio-emotional deficit via a defect in communication and social reciprocity, and a behavioral deficit which manifests itself in repetitive behavioral patterns (stereotypes), restricted interests and/or activities.
Characterized by regroup substance use disorders and behavioral addictions, are characterized in particular by the repeated occurrence of compulsive behavior and impaired social functioning
Adult without neurological and psychiatric history, absence of progressive somatic pathologies or with vital risk.
Diagnostic tests: MRI, EEG
Sites
3 sites in 1 country